What is PneumaCare?
PneumaCare Ltd is at the forefront of respiratory diagnostics, leveraging its proprietary Structured Light Plethysmography (SLP) technology. This innovative, non-contact method provides non-invasive and non-aerosol generating solutions for assessing lung function in both pediatric and adult patients. Their product suite, including the Thora-3Di systems and PneumaView 3D, offers real-time monitoring capabilities, aiming to revolutionize diagnostic pathways and elevate patient care within the respiratory medicine field. The company's focus on healthcare providers and researchers underscores its commitment to advancing medical technology.
How much funding has PneumaCare raised?
PneumaCare has raised a total of $1.6M across 1 funding round:
Unspecified
$1.6M
Unspecified (2013): $1.6M with participation from Cambridge Angels
Key Investors in PneumaCare
Cambridge Angels
Cambridge Angels is a prominent UK business angel network that provides smart capital from entrepreneurs to entrepreneurs, having supported over 150 companies since its inception in 2001. The network consists primarily of exited entrepreneurs with expertise in tech and healthcare, and membership is capped at 65 to maintain quality. They offer a clearly defined investment process, free office hours for entrepreneurs, and host various events to foster collaboration within the Cambridge ecosystem. Cambridge Angels is committed to diversity, actively increasing the representation of women and LGBTQ+ members.
What's next for PneumaCare?
With a major strategic investment and enterprise-level funding context, PneumaCare is likely entering a critical growth phase. This capital infusion is expected to fuel product development, enhance manufacturing capabilities, and expand market reach, potentially targeting new geographical regions or healthcare segments. The company's focus on non-invasive respiratory assessment positions it well to capitalize on the growing demand for advanced diagnostic tools in healthcare. Future strategic moves may involve further technological integration or partnerships to solidify its market leadership in respiratory imaging systems.
See full PneumaCare company page
